What is QTest Labs?
QTest Labs operates as a specialized Contract Research Organization (CRO) that bridges the critical gap between early-stage discovery and formal pre-clinical trials. The firm distinguishes itself through a deep focus on cardiovascular safety and mechanistic risk assessment, providing pharmaceutical and medical device developers with actionable data that transcends standard regulatory requirements. By integrating advanced scientific methodologies with predictive modeling, QTest Labs enables its clients to mitigate development risks and optimize the safety profiles of their therapeutic candidates. This market position is essential for firms looking to reduce lead times while maintaining rigorous scientific standards in an increasingly complex regulatory environment.
How much funding has QTest Labs raised?
QTest Labs has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
Key Investors in QTest Labs
PPP
Public-Private Partnership
What's next for QTest Labs?
With the recent influx of capital, QTest Labs is poised to scale its infrastructure and enhance its proprietary research platforms. The strategic focus will likely shift toward deepening its mechanistic understanding of complex test articles and expanding its service offerings to meet the growing demand for high-fidelity safety data. As the company matures, this late-stage financing provides the necessary runway to solidify its reputation as a leader in cardiovascular risk mitigation, potentially attracting further institutional interest as it continues to refine its predictive efficacy models for global life sciences partners.
See full QTest Labs company page
